Tolerability and Efficacy of Adjunctive Lamotrigine in Youth with Bipolar I Disorder: Preliminary Findings From the Open-Label Phase

Wednesday, October 19, 2011 2:30 PM

Kiki D. Chang, M.D., Psychiatry, Stanford University School of Medicine, Palo Alto, CA

Vicki Foster, M.P.H., GlaxoSmithKline, Raleigh, NC

Sherrie Li, B.A., Pediatric Bipolar Disorders Program, Stanford University School of Medicine, Stanford, CA

Anne Hammer, B.S., GlaxoSmithKline, NC

Joseph P. Horrigan, M.D., GlaxoSmithKline, Durham, NC


Please note that this schedule is subject to change. The Program Book distributed at the Annual Meeting will have final information on dates, times, and speakers for each presentation.

Symposium Presentation 12.4 Tolerability and Efficacy of Adjunctive Lamotrigine in Youth with Bipolar I Disorder: Preliminary Findings From the Open-Label Phase